MedTrace Logo

A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients

NCT01548716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2012-03-08

No results posted yet for this study

Summary

Hypothesis:

25-hydroxy vitamin D levels in non-itching hemodialysis (HD) patients will be higher than those in HD patients with itching

25-hydroxy vitamin D levels will be measured in non-itching hemodialysis patients and compared to levels previously measured in a previous study of 25-hydroxy vitamin D levels of patients complaining of itching.

Conditions

Sponsors & Collaborators

  • National Kidney Foundation, United States

    collaborator OTHER

  • Winthrop University Hospital

    lead OTHER

Principal Investigators

  • Mary Schanler, RD · Winthrop University Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2011-10-31
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01548716 on ClinicalTrials.gov